Back to Search
Start Over
Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS
- Source :
- Nature Reviews Drug Discovery, Nature Reviews Drug Discovery, Nature Publishing Group, 2017, 16 (1), pp.1-2. ⟨10.1038/nrd.2016.205⟩, Digital.CSIC. Repositorio Institucional del CSIC, instname, Nature Reviews Drug Discovery, 2017, 16 (1), pp.1-2. ⟨10.1038/nrd.2016.205⟩
- Publication Year :
- 2016
- Publisher :
- Springer Science and Business Media LLC, 2016.
-
Abstract
- Despite the vast amount of research on schizophrenia and depression in the past two decades, there have been few innovative drugs to treat these disorders. Precompetitive research collaborations between companies and academic groups can help tackle this innovation deficit, as illustrated by the achievements of the IMI-NEWMEDS consortium.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Drug Industry
Schizophrenia (object-oriented programming)
MEDLINE
03 medical and health sciences
0302 clinical medicine
Neural Pathways
Drug Discovery
medicine
Humans
Psychiatry
Drug industry
Depression (differential diagnoses)
Pharmacology
Depressive Disorder
Drug discovery
business.industry
Mental Disorders
General Medicine
Antidepressive Agents
030104 developmental biology
Schizophrenia
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Psychiatric disorders
business
Biomarkers
030217 neurology & neurosurgery
Antipsychotic Agents
Subjects
Details
- ISSN :
- 14741784 and 14741776
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- Nature Reviews Drug Discovery
- Accession number :
- edsair.doi.dedup.....96ae035a2593867e1bc2a09418386a5a
- Full Text :
- https://doi.org/10.1038/nrd.2016.205